Keyphrases
Liver Transplantation
100%
Leiomyomatosis Peritonealis Disseminata
50%
Non-colorectal Non-neuroendocrine Liver Metastasis
50%
Metastatic Colorectal Cancer (mCRC)
50%
Europe
50%
International Survey
50%
Surgeons
50%
Liver Surgery
50%
Endoscopic Surgery
50%
Italian Society
50%
Poor Outcome
50%
Tacrolimus
50%
Inter-patient Variability
50%
Color Image Processing
50%
Perihilar Cholangiocarcinoma
50%
Localized Disease
50%
R1 Resection
50%
Palliative Chemotherapy
50%
Unresected
50%
Early-onset Colorectal Cancer (EOCRC)
50%
COVID-19 Pandemic Impact
50%
Coefficient of Variation
40%
Liver Resection
30%
Postoperative Complications
30%
High Variability
30%
Overall Survival
28%
Clinical Trials
28%
Clinical Course
25%
Postmenopausal Women
25%
Benign Nodule
25%
Smooth muscle Cells
25%
Microscopic Examination
25%
Macroscopic Appearance
25%
Hormonal Influence
25%
40 Years Old
25%
Peritoneal Carcinomatosis
25%
Older Women
25%
Systemic Chemotherapy
21%
Open Approach
20%
Liver
20%
Patient Selection
20%
Liver-limited Disease
20%
5-year Survival
20%
Selection Criteria
20%
Clinical Outcomes
20%
Colorectal Cancer
20%
Low Variability
20%
Renal Function
20%
Post-liver Transplantation
20%
Inclusion Criteria
18%
Medicine and Dentistry
Liver Transplantation
100%
Colorectal Carcinoma
69%
Surgeon
62%
Leiomyomatosis
50%
Liver Metastasis
50%
Liver Surgery
50%
Endoscopic Surgery
50%
Metastatic Colorectal Cancer
50%
Tacrolimus
50%
Fatty Liver
50%
Photograph
50%
Surgery
50%
Localized Disease
50%
Cholangiocarcinoma
50%
COVID-19
50%
Overall Survival
44%
Diseases
40%
Postoperative Complication
30%
Hepatectomy
30%
Kidney Function
30%
Clinical Trial
28%
Carcinomatous Peritonitis
25%
Premenopause
25%
Smooth Muscle Cell
25%
Disease Course
25%
Microscopy
25%
Brain Death
25%
Metastatic Carcinoma
20%
Hazard Ratio
15%
Needle Biopsy
12%
Steatosis
12%
Health Care Cost
12%
Cancer
10%
Primary Tumor
10%
Cohort Effect
10%
General Surgery
10%
Unit Surgery
10%
Nuclear Medicine
10%
Biological Marker
10%
Liquid Biopsy
10%
Patient Selection
10%
Biopsy
10%
Liver Graft
10%
Cohort Analysis
10%
Immunosuppressive Drug
10%
Pharmacokinetics
10%
Surgery
10%
Survival Rate
10%
Odds Ratio
10%
Surgical Mortality
10%
